Literature DB >> 16229009

History of Wilson's disease: 1912 to 2000.

John M Walshe1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16229009     DOI： 10.1002/mds.20694

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  6 in total

Review 1.  Current anti-copper therapies in management of Wilson disease.

Authors:  Isabelle Mohr; Karl Heinz Weiss
Journal:  Ann Transl Med       Date:  2019-04

2.  Mo-Cu metal cluster formation and binding in an orange protein isolated from Desulfovibrio gigas.

Authors:  Marta S P Carepo; Sofia R Pauleta; Anthony G Wedd; José J G Moura; Isabel Moura
Journal:  J Biol Inorg Chem       Date:  2014-01-30       Impact factor: 3.358

3.  Cardiac assessment in Wilson's disease patients based on electrocardiography and echocardiography examination.

Authors:  Małgorzata Buksińska-Lisik; Tomasz Litwin; Tomasz Pasierski; Anna Członkowska
Journal:  Arch Med Sci       Date:  2017-09-07       Impact factor: 3.318

Review 4.  The Role of Zinc in the Treatment of Wilson's Disease.

Authors:  Abolfazl Avan; Anna Członkowska; Susan Gaskin; Alberto Granzotto; Stefano L Sensi; Tjaard U Hoogenraad
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

5.  Management of Children and Adolescents with Wilson Disease and Neurological Worsening Following D-Penicillamine Therapy: A Single Centre Experience.

Authors:  Madhan Kumar; T P Murugan; Arul P Lionel; Maya M Thomas; Pavithra Mannam; Sangeetha Yoganathan
Journal:  Ann Indian Acad Neurol       Date:  2022-09-09       Impact factor: 1.714

6.  GanDouLing combined with Penicillamine improves cerebrovascular injury via PERK/eIF2α/CHOP endoplasmic reticulum stress pathway in the mouse model of Wilson's disease.

Authors:  Yonghua Chen; Bo Zhang; Shijian Cao; Wei Huang; Ni Liu; Wenming Yang
Journal:  Biosci Rep       Date:  2018-09-19       Impact factor: 3.840
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.